The efficacy of antidepressants in the treatment of late-life depression

Journal of Clinical Psychopharmacology

Volumn 25, Issue 4 SUPPL. 1, 2005, Pages

  Roose, Steven P ^a   Schatzberg, Alan F ^b  

^a Columbia University ^*  (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; MIRTAZAPINE; NORTRIPTYLINE; PAROXETINE; PLACEBO; SERTRALINE; VENLAFAXINE;

AGING; CLINICAL TRIAL; COMORBIDITY; CONFERENCE PAPER; DEMOGRAPHY; DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; HUMAN; META ANALYSIS; METHODOLOGY; ONSET AGE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOSOCIAL CARE; REMISSION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 23044438927     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000162807.84570.6b     Document Type: Conference Paper

References (21)

1. Nelson JC, Kennedy JS, Pollock BG, et al. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease. Am J Psychiatry. 1999;156:1024-1028.
2. Mulsant BH, Pollock BG, Nebes R, et al. A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients. Am J Geriatr Psychiatry. 2001;9: 406-414.
3. Navarro V, Gasto C, Torres X, et al. Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study. Acta Psychiatr Scand. 2001;103:435-440.
4. Schweizer E, Rickeis K, Amsterdam JD, et al. What constitutes an adequate antidepressant trial for fluoxetine? J Clin Psychiatry. 1990;51:8-11.
5. Sackeim HA, Roose SP, Burt T. Optimal length of antidepressant trial in late-life depression. J Clin Psychopharmacol. 2005;25(suppl):S34-S37.
6. Wilson K, Mottram P, Sivanranthan A, et al. Antidepressants versus placebo for the depressed elderly. Cochrane Database Syst Rev. 2001; 2:CD000561.
7. Schatzberg AF, Cantillon M. Antidepressant early response and remission of venlafaxine and fluoxetine in geriatric outpatients. Eur Neuropsychopharmacol. 2000;10(suppl):S225-S226.
8. Newhouse PA, Krishnan KR, Doraiswamy PM, et al. A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients. J Clin Psychiatry. 2000;61:559-568.
9. Rapaport MH, Schneider LS, Dunner DL, et al. Efficacy of controlled-release paroxetine in the treatment of late-life depression. J Clin Psychiatry. 2003;64:1065-1074.
10. Keller MB. Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA. 2003; 289:3152-3160.
11. Roose SP, Sackeim HA, Krishnan KR, et al. Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry. 2004;161:2050-2059.
12. Bondareff W, Alpert M, Friedhoff AJ, et al. Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. Am J Psychiatry. 2000;157:729-736.
13. Schatzberg AF, Kremer C, Rodrigues HE, et al. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. Am J Geriatr Psychiatry. 2002;10:541-550.
14. Williams JW Jr, Barrett J, Oxman T, et al. Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults. JAMA. 2000;284:1519-1526.
15. Tollefson GD, Bosomworth JC, Heiligenstein JH, et al. A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group. Int Psychogeriatr. 1995;7:89-104.
16. Karp JF, Roose SP, Pesce V, et al. Redefining remission in late-life depression. Paper presented at: Annual Meeting of the American Academy for Geriatric Psychiatry; February 23-26, 2001: San Francisco, CA.
17. Schatzberg AF, Kraemer HC. Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression. Biol Psychiatry. 2000;47:736-744.
18. Fawcett J, Epstein P, Fiester SJ, et al. Clinical management-imipramine/ placebo administration manual. NIMH Treatment of Depression Collaborative Research Program. Psychopharmacol Bull. 1987; 23:309-324.
19. Schneider L, Nelson JC, Clary CM, et al. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry. 2003; 160:1277-1285.
20. Mamdani MM, Parikh SV, Austin PC, et al. Use of antidepressants among elderly subjects: trends and contributing factors. Am J Psychiatry. 2000;157:360-367.
21. Katona C, Livingston G. How well do antidepressants work in older people? A systematic review of number needed to treat. J Affect Disord. 2002;69:47-52.